[ Back to EurekAlert! ]

Contact: Teresa Herbert
teresa_herbert@dfci.harvard.edu
617-632-4090
Dana-Farber Cancer Institute

Irene Ghobrial, Dana-Farber Cancer Institute

Caption: Dr. Irene Ghobrial led a study showing a drug that targets the driver mutation in patients with Waldenstrom's Macrogloblinemia is proving effective in animal studies.

Credit: Dana-Farber Cancer Institute

Usage Restrictions: None

Related news release: Gene 'driver' of Waldenstrom's Macroglobulinemia in up to one-third of patients identified


[ Back to EurekAlert! ]